Auransa

auransa.com

Auransa is a clinical stage drug development company that aims to invent high value, novel drugs for hard-to-treat diseases like cancer, auto-immune, and neurological disorders using its proprietary AI platform and drug discovery expertise. The company's platform is used to understand the biology of diseases at subtype level resolution, enabling it to predict compounds and targets of novel pharmacology for responder patient populations. The current internal drug pipeline includes a first-in-class investigational new drug for cancer in clinical trials. Auransa has partnerships with companies and institutions in the biopharma industry.